Please enable JavaScript to continue using this application.

Compare $LEGN vs $RLAY | Chartloom

Compare

$LEGN vs $RLAY

Legend Biotech Corp · Relay Therapeutics Inc

LEGN

Legend Biotech Corp

RLAY

Relay Therapeutics Inc

Compare $LEGN vs $RLAY

Comparing Legend Biotech Corp and Relay Therapeutics Inc

LEGNLegend Biotech Corp

RLAYRelay Therapeutics Inc

LEGNLegend Biotech Corp

Market cap

$3.62B

P/E (TTM)

—

Forward P/E (NTM)

25.42x

Forward P/S (NTM)

2.17x

Rev growth (TTM)

59.6%

YTD performance

-13.4%

52W performance

-42.2%

FCF yield

-3.4%

RLAYRelay Therapeutics Inc

Market cap

$3.85B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

610.65x

Rev growth (TTM)

23.9%

YTD performance

118.6%

52W performance

192.6%

FCF yield

-5.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LEGN

RLAY

Detailed metrics comparison

LEGN

Legend Biotech Corp

RLAY

Relay Therapeutics Inc

Market Cap

LEGN$3.62B

RLAY$3.85B

Enterprise Value

LEGN$3.23B

RLAY$3.73B

Price

LEGN$18.62

RLAY$17.88

P/E Ratio

LEGNN/A

RLAYN/A

P/S Ratio

LEGN2.85x

RLAY372.39x

EV/Sales

LEGN2.54x

RLAY360.68x

EV/EBITDA

LEGN0.00x

RLAY0.00x

P/B Ratio

LEGN3.04x

RLAY4.67x

P/FCF Ratio

LEGNN/A

RLAYN/A

EV/FCF

LEGN-26.50x

RLAY-17.59x

PEG Ratio

LEGNN/A

RLAYN/A

Forward P/E (NTM)

LEGN25.42x

RLAYN/A

Forward P/S (NTM)

LEGN2.17x

RLAY610.65x

Revenue (TTM)

LEGN$1.27B

RLAY$10M

Revenue Growth (YoY)

LEGN59.6%

RLAY23.9%

Forward Rev Growth

LEGN25.0%

RLAY64.1%

Gross Margin (TTM)

LEGN56.6%

RLAY0.0%

Operating Margin (TTM)

LEGN0.0%

RLAY0.0%

EBITDA Margin (TTM)

LEGN-0.8%

RLAY-2978.0%

Net Margin (TTM)

LEGN-7.2%

RLAY-2763.6%

FCF Margin (TTM)

LEGN-9.6%

RLAY-2050.3%

Net Income (TTM)

LEGN$-92M

RLAY$-286M

FCF (TTM)

LEGN$-122M

RLAY$-212M

EPS (TTM)

LEGN-$0.47

RLAY-$1.41

ROE (TTM)

LEGN-870.0%

RLAY-4227.0%

ROA (TTM)

LEGN-539.0%

RLAY-3867.0%

ROIC (TTM)

LEGN-643.0%

RLAY-4227.0%

Cash

LEGN$673M

RLAY$121M

Debt

LEGN$278M

RLAY$0

Net Cash/Debt

LEGN$395M

RLAY$121M

Current Ratio (TTM)

LEGN3.04x

RLAY18.27x

Quick Ratio (TTM)

LEGN2.89x

RLAY18.10x

Debt/Equity (TTM)

LEGN0.23x

RLAY0.00x

Debt/Assets (TTM)

LEGN0.0%

RLAY0.0%

Interest Coverage (TTM)

LEGNN/A

RLAYN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

RLAY0.00x

Beta

LEGN0.57

RLAY1.71

52W Performance

LEGN-42.2%

RLAY192.6%

YTD Performance

LEGN-13.4%

RLAY118.6%

% from 52W High

LEGN-50.3%

RLAY-15.9%

% from 52W Low

LEGN14.7%

RLAY205.6%

Asset Turnover (TTM)

LEGN0.75x

RLAY0.01x

FCF Yield (TTM)

LEGN-3.4%

RLAY-5.5%

Earnings Yield (TTM)

LEGN-2.5%

RLAY-7.4%

Dividend Yield (TTM)

LEGNN/A

RLAYN/A

Rule of 40

LEGN50.0

RLAY-2,026.4

EV/GP/RG

LEGN0.13

RLAYN/A

Ticker research

View LEGN research View RLAY research

Metric	LEGN Legend Biotech Corp	RLAY Relay Therapeutics Inc
Market & Valuation
Market Cap	$3.62B	$3.85B
Enterprise Value	$3.23B	$3.73B
Price	$18.62	$17.88
P/E Ratio	N/A	N/A
P/S Ratio	2.85x	372.39x
EV/Sales	2.54x	360.68x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.04x	4.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.50x	-17.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.42x	N/A
Forward P/S (NTM)	2.17x	610.65x
Revenue & Growth
Revenue (TTM)	$1.27B	$10M
Revenue Growth (YoY)	59.6%	23.9%
Forward Rev Growth	25.0%	64.1%
Profitability
Gross Margin (TTM)	56.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.8%	-2978.0%
Net Margin (TTM)	-7.2%	-2763.6%
FCF Margin (TTM)	-9.6%	-2050.3%
Net Income (TTM)	$-92M	$-286M
FCF (TTM)	$-122M	$-212M
EPS (TTM)	-$0.47	-$1.41
ROE (TTM)	-870.0%	-4227.0%
ROA (TTM)	-539.0%	-3867.0%
ROIC (TTM)	-643.0%	-4227.0%
Financial Health
Cash	$673M	$121M
Debt	$278M	$0
Net Cash/Debt	$395M	$121M
Current Ratio (TTM)	3.04x	18.27x
Quick Ratio (TTM)	2.89x	18.10x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	1.71
52W Performance	-42.2%	192.6%
YTD Performance	-13.4%	118.6%
% from 52W High	-50.3%	-15.9%
% from 52W Low	14.7%	205.6%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.01x
FCF Yield (TTM)	-3.4%	-5.5%
Earnings Yield (TTM)	-2.5%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	-2,026.4
EV/GP/RG	0.13	N/A
Ticker research	View LEGN research	View RLAY research

Valuation

P/S Ratio

LEGN

2.85x

RLAY

372.39x

EV/FCF

LEGN

-26.50x

RLAY

-17.59x

Growth & revenue

Revenue Growth TTM

LEGN

59.6%

RLAY

23.9%

Forward Revenue Growth

RLAY

64.1%

LEGN

25.0%

Profitability & performance

Gross Margin

LEGN

56.6%

RLAY

0.0%

ROE

LEGN

-870.0%

RLAY

-4227.0%

FCF Yield %

LEGN

-3.4%

RLAY

-5.5%

52-Week Performance

RLAY

192.6%

LEGN

-42.2%

Detailed metrics comparison

LEGN

Legend Biotech Corp

RLAY

Relay Therapeutics Inc

Market Cap

LEGN$3.62B

RLAY$3.85B

Enterprise Value

LEGN$3.23B

RLAY$3.73B

Price

LEGN$18.62

RLAY$17.88

P/E Ratio

LEGNN/A

RLAYN/A

P/S Ratio

LEGN2.85x

RLAY372.39x

EV/Sales

LEGN2.54x

RLAY360.68x

EV/EBITDA

LEGN0.00x

RLAY0.00x

P/B Ratio

LEGN3.04x

RLAY4.67x

P/FCF Ratio

LEGNN/A

RLAYN/A

EV/FCF

LEGN-26.50x

RLAY-17.59x

PEG Ratio

LEGNN/A

RLAYN/A

Forward P/E (NTM)

LEGN25.42x

RLAYN/A

Forward P/S (NTM)

LEGN2.17x

RLAY610.65x

Revenue (TTM)

LEGN$1.27B

RLAY$10M

Revenue Growth (YoY)

LEGN59.6%

RLAY23.9%

Forward Rev Growth

LEGN25.0%

RLAY64.1%

Gross Margin (TTM)

LEGN56.6%

RLAY0.0%

Operating Margin (TTM)

LEGN0.0%

RLAY0.0%

EBITDA Margin (TTM)

LEGN-0.8%

RLAY-2978.0%

Net Margin (TTM)

LEGN-7.2%

RLAY-2763.6%

FCF Margin (TTM)

LEGN-9.6%

RLAY-2050.3%

Net Income (TTM)

LEGN$-92M

RLAY$-286M

FCF (TTM)

LEGN$-122M

RLAY$-212M

EPS (TTM)

LEGN-$0.47

RLAY-$1.41

ROE (TTM)

LEGN-870.0%

RLAY-4227.0%

ROA (TTM)

LEGN-539.0%

RLAY-3867.0%

ROIC (TTM)

LEGN-643.0%

RLAY-4227.0%

Cash

LEGN$673M

RLAY$121M

Debt

LEGN$278M

RLAY$0

Net Cash/Debt

LEGN$395M

RLAY$121M

Current Ratio (TTM)

LEGN3.04x

RLAY18.27x

Quick Ratio (TTM)

LEGN2.89x

RLAY18.10x

Debt/Equity (TTM)

LEGN0.23x

RLAY0.00x

Debt/Assets (TTM)

LEGN0.0%

RLAY0.0%

Interest Coverage (TTM)

LEGNN/A

RLAYN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

RLAY0.00x

Beta

LEGN0.57

RLAY1.71

52W Performance

LEGN-42.2%

RLAY192.6%

YTD Performance

LEGN-13.4%

RLAY118.6%

% from 52W High

LEGN-50.3%

RLAY-15.9%

% from 52W Low

LEGN14.7%

RLAY205.6%

Asset Turnover (TTM)

LEGN0.75x

RLAY0.01x

FCF Yield (TTM)

LEGN-3.4%

RLAY-5.5%

Earnings Yield (TTM)

LEGN-2.5%

RLAY-7.4%

Dividend Yield (TTM)

LEGNN/A

RLAYN/A

Rule of 40

LEGN50.0

RLAY-2,026.4

EV/GP/RG

LEGN0.13

RLAYN/A

Ticker research

View LEGN research View RLAY research

Metric	LEGN Legend Biotech Corp	RLAY Relay Therapeutics Inc
Market & Valuation
Market Cap	$3.62B	$3.85B
Enterprise Value	$3.23B	$3.73B
Price	$18.62	$17.88
P/E Ratio	N/A	N/A
P/S Ratio	2.85x	372.39x
EV/Sales	2.54x	360.68x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.04x	4.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.50x	-17.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.42x	N/A
Forward P/S (NTM)	2.17x	610.65x
Revenue & Growth
Revenue (TTM)	$1.27B	$10M
Revenue Growth (YoY)	59.6%	23.9%
Forward Rev Growth	25.0%	64.1%
Profitability
Gross Margin (TTM)	56.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.8%	-2978.0%
Net Margin (TTM)	-7.2%	-2763.6%
FCF Margin (TTM)	-9.6%	-2050.3%
Net Income (TTM)	$-92M	$-286M
FCF (TTM)	$-122M	$-212M
EPS (TTM)	-$0.47	-$1.41
ROE (TTM)	-870.0%	-4227.0%
ROA (TTM)	-539.0%	-3867.0%
ROIC (TTM)	-643.0%	-4227.0%
Financial Health
Cash	$673M	$121M
Debt	$278M	$0
Net Cash/Debt	$395M	$121M
Current Ratio (TTM)	3.04x	18.27x
Quick Ratio (TTM)	2.89x	18.10x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	1.71
52W Performance	-42.2%	192.6%
YTD Performance	-13.4%	118.6%
% from 52W High	-50.3%	-15.9%
% from 52W Low	14.7%	205.6%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.01x
FCF Yield (TTM)	-3.4%	-5.5%
Earnings Yield (TTM)	-2.5%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	-2,026.4
EV/GP/RG	0.13	N/A
Ticker research	View LEGN research	View RLAY research